March 27th 2023
In a recent study, the risk of developing breast cancer was greater in women with current or recent use of progestogen-only contraceptives.
March 17th 2023
March 2nd 2023
February 17th 2023
Opioid use disorder and contraceptionJanuary 19th 2023
Women on Medicaid with opioid use disorder (OUD) who use medications for opioid use disorder (MOUD) are more likely to use contraception and to undergo female sterilization than peers not prescribed MOUD, according to a study in Contraception.
Hormonal contraceptives and adverse effects: What’s the evidence?January 10th 2023
An umbrella review of meta-analysis studies on hormonal contraceptives published in JAMA Network Open finds no high-quality evidence that they cause major adverse health outcomes such as stroke or cancer.
Changes in the clinical workforce for contraception and abortion careJanuary 6th 2023
The contraception and abortion care workforce in the United States significantly decreased during the first year of the COVID-19 pandemic, according to a research letter published in JAMA Network Open.
Frequency of condomless sex among women using reversible methods of contraceptionJanuary 4th 2023
A substudy of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which compared three highly effective, reversible methods of contraception, concluded that women assigned either a copper intrauterine device (Cu-IUD) or the levonorgestrel (LNG) implant may have had condomless sex more frequently than women assigned to intramuscular depo-medroxyprogesterone acetate (DMPA-IM).
Preventing unintended pregnancies with an OTC progestin-only pillNovember 8th 2022
An over-the-counter (OTC) progestin only pill (POP) could potentially reduce the overall number of unintended pregnancies in the United States, according to a modeling study published in the journal Contraception.
Consensus statement on Rh pregnancy testingNovember 2nd 2022
Rhesus (Rh) immunoglobulin should be given only after 12 weeks gestation for spontaneous abortion, or for medication or uterine aspiration abortion, according to a new consensus statement from the Society of Family Planning (SFP).
Title X clinics offer same quality of contraceptive counseling as private health careOctober 25th 2022
Federal health programs that provide services to economic and racial minorities may have a reputation for providing less empathetic or patient-centered care than private health care institutions, but a new study shows that—at least in contraceptive counseling¬—that’s not the case.
Abortion restrictions during COVID-19 pandemicOctober 24th 2022
A study in the journal Contraception found that, within the first year of the COVID-19 pandemic in the US, abortion clinics in states with low or medium hostility to abortion were significantly more likely to embrace innovative medication abortion practices such as changing ultrasound requirements, offering telehealth or dispensing medications without a physical exam, compared to abortion clinics in states with high or extreme hostility to abortion.
The fact that copper-containing intrauterine devices (Cu-IUDs) can increase bleeding and discontinuation rates compared to levonorgestrel-releasing IUDs (LNG-IUDs) does not mean clinicians should steer patients toward the latter, according to a review published in BMC Women’s Health. Due to high satisfaction rates with both devices, authors recommend letting patients choose based on their needs and preferences.